This is a Validated Antibody Database (VAD) review about human FOP, based on 5 published articles (read how Labome selects the articles), using FOP antibody in all methods. It is aimed to help Labome visitors find the most suited FOP antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FOP synonym: FGFR1OP; FOP
Knockout validation
Abnova mouse monoclonal (2B1) |
| In order to study the association of IFT-B with CEP19-RABL2 GTPase complex and it role in intraflagellar transport, Abnova FOP antibody (NOVUS, H00011116-M01) was used in immunocytochemistry knockout validation on human samples (fig 2g). Dev Cell (2017) ncbi |
Abnova
mouse monoclonal (2B1) |
| Abnova FOP antibody (Abnova, H00011116-M01) was used in immunohistochemistry on mouse samples at 1:250 (fig 1b) and in western blot on mouse samples at 1:1000 (fig 1g). Nat Commun (2021) ncbi |
mouse monoclonal (2B1) |
| Abnova FOP antibody (Abnova, 2B1) was used in immunocytochemistry on human samples at 1:10,000 (fig 1a''). Biol Open (2021) ncbi |
mouse monoclonal (2B1) |
| Abnova FOP antibody (Abnova Corporation, H00011116-M01) was used in immunohistochemistry on mouse samples at 1:600 (fig 2d). Neuron (2019) ncbi |
mouse monoclonal (2B1) |
| In order to study the association of IFT-B with CEP19-RABL2 GTPase complex and it role in intraflagellar transport, Abnova FOP antibody (NOVUS, H00011116-M01) was used in immunocytochemistry knockout validation on human samples (fig 2g). Dev Cell (2017) ncbi |
mouse monoclonal (2B1) |
| In order to research the role of intraflagellar transport-A complex in ciliary entry and retrograde trafficking, Abnova FOP antibody (Abnova, 2B1) was used in immunocytochemistry on human samples at 1:10,000 (fig 5a''). Mol Biol Cell (2017) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments